Pfizer Seeks COVID Shot Authorization for Children Under 5
February 1, 2022, Pfizer/BioNTech asked the U.S. Food and Drug Administration to grant emergency use authorization (EUA) for their COVID shot to babies and children aged 6 months through 4 years The EUA will be for a two-dose regimen, with the possibility of extending it to a third dose, as two …
Read More